Ascendis Pharma A/S vs Badger Meter Inc — how do they compare? Ascendis Pharma A/S trades at $254.5 (market cap $16.67B), while Badger Meter Inc trades at $135.56 (market cap $3.93B). The key difference: Ascendis Pharma A/S is far larger — about 4.2× Badger Meter Inc's market cap, and Badger Meter Inc pays a 1.18% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | BMI | |
|---|---|---|
Market Cap | $16.67B | $3.93B |
Sector | Health | Technology |
52-Week High | $277.18 | $193.09 |
52-Week Low | $189.74 | $113.41 |
Enterprise Value | $17.04B | $3.84B |
Dividend Yield | — | 1.18% |
Trailing returns across standard periods
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →Badger Meter provides industry-leading water management solutions. Its smart measurement hardware and software analytics help water utilities and industrial customers optimize operations and conserve natural resources.
Read more on BMI →